Key Insights

Highlights

Treatment Research

3 treatments under study, led by Adults With Alzheimers Disease

Related Conditions

Often studied with 13 related conditions

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 100/100

Termination Rate

50.0%

1 terminated out of 2 trials

Success Rate

0.0%

-86.6% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

0

Data Visualizations

Phase Distribution

1Total
Not Applicable (1)

Trial Status

Recruiting1
Terminated1

Clinical Trials (2)

Showing 2 of 2 trials
NCT06523296Not ApplicableTerminated

Presence of Anti-RACH Antibodies and Neurocognitive Disorder in Myasthenic or Alzheimers's Patients.

NCT06617741Recruiting

Myasthenia Gravis Foundation of America Global MG Patient Registry

Showing all 2 trials

Research Network

Common Treatments

  • Adults With Alzheimers Disease1
  • Adults With Myasthenia1
  • Healhty Controls1

Active Sponsors

  • Alira Health1
  • Centre Hospitalier Universitaire de Nice1
  • Myasthenia Gravis Foundation of America1

Top Investigators

Related Conditions

  • Myasthaenia Gravis1
  • Myasthenia Gravis Generalised1
  • Alzheimer Disease1
  • Myasthenia Gravis Ocular1
  • Myasthenia Gravis1

Activity Timeline